Finally the highest immunoreactive score for B7-H6 were observed in tumor cells of uterine cervical adenocarcinoma, suggesting B7-H6 as a possible immunotherapeutic target that could be address in the treatment for this type of cervical cancer. This evidence concerns the gene NCR3LG1 and cervical cancer.